ADC Therapeutics SA H0036K147 06/01/2026 Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive Officers. The Board of Directors proposes that the following proposal: RESOLVED, that the Company's Shareholders approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in Executive Compensation and the related compensation tables and narrative disclosure in this proxy statement, be approved. SECTION 14A SAY-ON-PAY VOTES ISSUER 12681731 0 FOR 12681731 FOR Akero Therapeutics, Inc. 00973Y108 12/02/2025 To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. SECTION 14A SAY-ON-PAY VOTES ISSUER 487013 0 FOR 487013 FOR ALX Oncology Holdings Inc. 00166B105 06/10/2026 Advisory vote to approve named executive officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7457788 0 AGAINST 7457788 AGAINST Annexon, Inc. 03589W102 US03589W1027 06/11/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 14549769 0 FOR 14549769 FOR Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission SECTION 14A SAY-ON-PAY VOTES ISSUER 641750 0 FOR 641750 FOR Ardelyx, Inc. 039697107 06/16/2026 To approve, on a non-binding, advisory basis, whether a Say-on-Pay vote should occur every one (1) year, every two (2) years or every three (3) years SECTION 14A SAY-ON-PAY VOTES ISSUER 641750 0 1 YEAR 641750 FOR Atara Biotherapeutics, Inc. 046513206 06/09/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 441701 0 FOR 441701 FOR Beam Therapeutics Inc. 07373V105 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 1164259 0 FOR 1164259 FOR BioMarin Pharmaceutical Inc. 09061G101 06/02/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 150559 0 AGAINST 150559 AGAINST Celldex Therapeutics, Inc. 15117B202 06/25/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 433921 0 FOR 433921 FOR Cogent Biosciences, Inc. 19240Q201 06/09/2026 Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 503321 0 FOR 503321 FOR DBV Technologies FR0010417345 06/03/2026 2025 Remuneration Policy (Named executive officers other than CEO) SECTION 14A SAY-ON-PAY VOTES ISSUER 900601 0 FOR 900601 FOR DBV Technologies 23306J309 06/03/2026 2025 Remuneration Policy (Named executive officers other than CEO) SECTION 14A SAY-ON-PAY VOTES ISSUER 410440 0 FOR 410440 FOR Establishment Labs Holdings Inc. G31249108 05/22/2026 To approve, on an advisory basis, the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 88964 0 FOR 88964 FOR Fate Therapeutics, Inc. 31189P102 06/12/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 12872946 0 FOR 12872946 FOR IDEAYA Biosciences, Inc. 45166A102 06/16/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders SECTION 14A SAY-ON-PAY VOTES ISSUER 455017 0 FOR 455017 FOR Immunome, Inc. 45257U108 06/09/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5345485 0 FOR 5345485 FOR Immunome, Inc. 45257U108 06/09/2026 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5345485 0 1 YEAR 5345485 FOR Krystal Biotech, Inc. 501147102 05/15/2026 Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis. SECTION 14A SAY-ON-PAY VOTES ISSUER 673505 0 FOR 673505 FOR LivaNova PLC G5509L101 06/10/2026 To approve, on an advisory basis, the Company's compensation of its named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 90822 0 FOR 90822 FOR Neurogene Inc. 64135M105 06/03/2026 To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 1446634 0 AGAINST 1446634 AGAINST Neurogene Inc. 64135M105 06/03/2026 To hold a non-binding advisory vote on whether future non-binding advisory votes on the compensation paid by the company to its named executive officers should be held every one, two or three years. SECTION 14A SAY-ON-PAY VOTES ISSUER 1446634 0 1 YEAR 1446634 FOR Nurix Therapeutics, Inc. 67080M103 05/15/2026 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 7902808 0 FOR 7902808 FOR Nuvation Bio Inc. 67080N101 05/21/2026 To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 3153256 0 FOR 3153256 FOR ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve, on an advisory basis, executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 362010 0 FOR 362010 FOR ORIC Pharmaceuticals, Inc. 68622P109 06/18/2026 To approve, on an advisory basis, the frequency of future advisory votes on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 362010 0 1 YEAR 362010 FOR Pliant Therapeutics, Inc. 729139105 06/11/2026 To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 772126 0 AGAINST 772126 AGAINST REGENXBIO Inc. 75901B107 05/29/2026 Advisory vote on the compensation paid to the Company's executive employees. SECTION 14A SAY-ON-PAY VOTES ISSUER 4368804 0 FOR 4368804 FOR Repare Therapeutics Inc. 760273102 01/16/2026 An ordinary resolution to approve, on an advisory and non-binding basis, the compensation to be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Arrangement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1586174 0 FOR 1586174 FOR Replimune Group, Inc. 76029N106 09/03/2025 To approve, on a non-binding advisory basis, the compensation of Replimune Group, Inc.'s named executive officers for the fiscal year ended March 31, 2025. SECTION 14A SAY-ON-PAY VOTES ISSUER 4546576 0 FOR 4546576 FOR Scholar Rock Holding Corporation 80706P103 06/04/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 8050111 0 FOR 8050111 FOR Shattuck Labs, Inc. 82024L103 05/28/2026 To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5539724 0 FOR 5539724 FOR Shattuck Labs, Inc. 82024L103 05/28/2026 To conduct an advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 5539724 0 1 YEAR 5539724 FOR Silence Therapeutics plc 82686Q101 06/16/2026 To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in this proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 1692527 0 FOR 1692527 FOR Solid Biosciences Inc. 83422E204 06/10/2026 The approval of an advisory vote on executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 1948695 0 FOR 1948695 FOR Stoke Therapeutics, Inc 86150R107 06/03/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 4077820 0 FOR 4077820 FOR Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the compensation of the Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 228344 0 FOR 228344 FOR Xenon Pharmaceuticals Inc. 98420N105 06/02/2026 To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 228344 0 1 YEAR 228344 FOR Zymeworks Inc. 98985Y108 12/30/2025 Advisory vote on the compensation of our named executive officers SECTION 14A SAY-ON-PAY VOTES ISSUER 923198 0 FOR 923198 FOR